CHRNA5 and lung cancer: And the nicotinic cholinergic receptor gene CHRNA5-CHRNA3-CHRNB4 located on 15q25 can influence the risk of lung cancer by affecting the nicotine dependence and downstream signaling pathways which contribute to increaser risk of lung cancer [37–40].